Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines - <I>Eli Lilly v. Canada</I> and the Trans-Pacific Partnership Agreement

The Trans-Pacific Partnership Agreement: a threat to affordable medicines and public health

PhRMA has long criticized medicines insurance schemes premised on cost-effectiveness and reference pricing such as the Pharmaceutical Benefits Scheme (PBS) in Australia and PHARMAC in New Zealand. The PhRMA submission to the USTR on the TTPA specifically targets alleged ‘market access barriers... inadequate consultative mechanisms and transparency concerns in countries like New Zealand’6. But t...

Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.

Intellectual property (IP) protections proposed by the United States for the Trans-Pacific Partnership Agreement (TPPA) have sparked widespread alarm about the potential negative impact on access to affordable medicines. The most recently leaked draft of the IP chapter shows some shifts in the US position, presumably in response to ongoing resistance from other countries. While some problematic...

The Trans-pacific Partnership Agreement: Some Critical Concerns

The Trans-Pacific Partnership Agreement (TPPA) involves twelve Pacific Rim economies of varying sizes and structures. Although often portrayed as a free trade agreement, the TPPA can, at best, be expected to deliver paltry overall growth gains from trade liberalization. The much higher figures touted by TPPA advocates are largely due to dubious ‘non-trade measures’, most of which have been reje...

The Trans-Pacific Partnership: Should We “Fear the Fear”?; Comment on “The Trans-Pacific Partnership: Is It Everything We Feared for Health?”

RLabonté et al entitle their paper in this issue of the International Journal of Health Policy and Management “The Trans-Pacific Partnership: Is It Everything We Feared for Health?” Tantalisingly, they do not directly answer the question they pose, and in this commentary, we suggest that it is the wrong question; we should not ‘fear’ the Trans-Pacific Partnership (TPP) at all, rather we should ...

The impact of Trans‐Pacific Partnership agreement on the Canadian economy